Corcept Therapeutics CORT Chief Commercial Officer · filings 2018 to 2026 · sold $62.9M · $65.6M noticed on Form 144
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Option or RSU exercised or converted | +13,159 | $8.27 | $109K | 23,097 direct | Filing · EDGAR |
| Nov 3, 2026 | Sale under a 10b5-1 plan | −8,617 | $82.02 | $707K | 14,480 direct | Filing · EDGAR |
| Nov 3, 2026 | Sale under a 10b5-1 plan | −4,542 | $82.68 | $376K | 9,938 direct | Filing · EDGAR |
| Nov 3, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −13,159 | 16,986 direct | Filing · EDGAR | ||
| Nov 2, 2026 | Option or RSU exercised or converted | +11,841 | $8.27 | $98K | 21,779 direct | Filing · EDGAR |
| Nov 2, 2026 | Sale under a 10b5-1 plan | −11,841 | $81.42 | $964K | 9,938 direct | Filing · EDGAR |
| Nov 2, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −11,841 | 30,145 direct | Filing · EDGAR | ||
| Oct 2, 2026 | Option or RSU exercised or converted | +24,587 | $8.27 | $203K | 34,525 direct | Filing · EDGAR |
| Oct 2, 2026 | Sale under a 10b5-1 plan | −15,843 | $116.12 | $1.8M | 18,682 direct | Filing · EDGAR |
| Oct 2, 2026 | Sale under a 10b5-1 plan | −8,744 | $116.55 | $1M | 9,938 direct | Filing · EDGAR |
| Oct 2, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −24,587 | 41,986 direct | Filing · EDGAR | ||
| Oct 1, 2026 | Option or RSU exercised or converted | +413 | $8.27 | $3K | 10,351 direct | Filing · EDGAR |
| Oct 1, 2026 | Sale under a 10b5-1 plan | −413 | $115.54 | $48K | 9,938 direct | Filing · EDGAR |
| Oct 1, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −413 | 66,573 direct | Filing · EDGAR | ||
| Sep 2, 2026 | Shares withheld for tax or exercise price | −117 | $113.38 | $13K | 9,938 direct | Filing · EDGAR |
| Sep 1, 2026 | Option or RSU exercised or converted | +25,000 | $8.27 | $207K | 34,755 direct | Filing · EDGAR |
| Sep 1, 2026 | Sale under a 10b5-1 plan | −11,730 | $113.94 | $1.3M | 23,025 direct | Filing · EDGAR |
| Sep 1, 2026 | Sale under a 10b5-1 plan | −10,989 | $114.71 | $1.3M | 12,036 direct | Filing · EDGAR |
| Sep 1, 2026 | Sale under a 10b5-1 plan | −2,281 | $115.61 | $264K | 9,755 direct | Filing · EDGAR |
| Sep 1, 2026 | Grant or award from the company | +150 | $113.38 | $17K | 9,905 direct | Filing · EDGAR |
| Sep 1, 2026 | Grant or award from the company | +150 | 10,055 direct | Filing · EDGAR | ||
| Sep 1, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −25,000 | 66,986 direct | Filing · EDGAR | ||
| Aug 25, 2026 | Option or RSU exercised or converted | +30,955 | $11.35 | $351K | 40,710 direct | Filing · EDGAR |
| Aug 25, 2026 | Sale under a 10b5-1 plan | −25,085 | $125.47 | $3.1M | 15,625 direct | Filing · EDGAR |
| Aug 25, 2026 | Sale under a 10b5-1 plan | −5,870 | $126.06 | $740K | 9,755 direct | Filing · EDGAR |
| Aug 25, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −30,955 | 169,045 direct | Filing · EDGAR | ||
| Aug 14, 2026 | Option or RSU exercised or converted | +3,664 | $8.27 | $30K | 13,419 direct | Filing · EDGAR |
| Aug 14, 2026 | Sale under a 10b5-1 plan | −3,664 | $114.49 | $419K | 9,755 direct | Filing · EDGAR |
| Aug 14, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −3,664 | 91,986 direct | Filing · EDGAR | ||
| Aug 10, 2026 | Option or RSU exercised or converted | +1,031 | $8.27 | $9K | 10,786 direct | Filing · EDGAR |
| Aug 10, 2026 | Sale under a 10b5-1 plan | −1,031 | $114.52 | $118K | 9,755 direct | Filing · EDGAR |
| Aug 10, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −1,031 | 95,650 direct | Filing · EDGAR | ||
| Aug 3, 2026 | Option or RSU exercised or converted | +20,305 | $8.27 | $168K | 30,060 direct | Filing · EDGAR |
| Aug 3, 2026 | Sale under a 10b5-1 plan | −20,305 | $114.70 | $2.3M | 9,755 direct | Filing · EDGAR |
| Aug 3, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −20,305 | 96,681 direct | Filing · EDGAR | ||
| Jul 1, 2026 | Option or RSU exercised or converted | +25,000 | $8.27 | $207K | 34,755 direct | Filing · EDGAR |
| Jul 1, 2026 | Sale under a 10b5-1 plan | −11,024 | $87.33 | $963K | 23,731 direct | Filing · EDGAR |
| Jul 1, 2026 | Sale under a 10b5-1 plan | −2,801 | $88.51 | $248K | 20,930 direct | Filing · EDGAR |
| Jul 1, 2026 | Sale under a 10b5-1 plan | −11,175 | $89.31 | $998K | 9,755 direct | Filing · EDGAR |
| Jul 1, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −25,000 | 116,986 direct | Filing · EDGAR | ||
| Jun 2, 2026 | Shares withheld for tax or exercise price | −452 | $70.44 | $32K | 9,755 direct | Filing · EDGAR |
| Jun 1, 2026 | Option or RSU exercised or converted | +25,000 | $8.27 | $207K | 33,977 direct | Filing · EDGAR |
| Jun 1, 2026 | Sale under a 10b5-1 plan | −21,069 | $70.11 | $1.5M | 12,908 direct | Filing · EDGAR |
| Jun 1, 2026 | Sale under a 10b5-1 plan | −3,931 | $70.75 | $278K | 8,977 direct | Filing · EDGAR |
| Jun 1, 2026 | Grant or award from the company | +615 | $70.44 | $43K | 9,592 direct | Filing · EDGAR |
| Jun 1, 2026 | Grant or award from the company | +615 | 10,207 direct | Filing · EDGAR | ||
| Jun 1, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −25,000 | 141,986 direct | Filing · EDGAR | ||
| May 27, 2026 | Option or RSU exercised or converted | +75,000 | $8.27 | $620K | 83,977 direct | Filing · EDGAR |
| May 27, 2026 | Sale under a 10b5-1 plan | −54,575 | $65.37 | $3.6M | 29,402 direct | Filing · EDGAR |
| May 27, 2026 | Sale under a 10b5-1 plan | −20,425 | $66.16 | $1.4M | 8,977 direct | Filing · EDGAR |
| May 27, 2026 | Option or RSU exercised or converted Stock option (right to buy) | −75,000 | 166,986 direct | Filing · EDGAR | ||
| Mar 3, 2026 | Shares withheld for tax or exercise price | −110 | $35.97 | $4K | 8,977 direct | Filing · EDGAR |
| Mar 2, 2026 | Grant or award from the company | +454 | $35.97 | $16K | 8,633 direct | Filing · EDGAR |
| Mar 2, 2026 | Grant or award from the company | +454 | 9,087 direct | Filing · EDGAR | ||
| Feb 27, 2026 | Grant or award from the company Stock Option (right to buy) | +140,000 | 140,000 direct | Filing · EDGAR | ||
| Jan 8, 2026 | Gift | −20,570 | 39,147 See Footnote | Filing · EDGAR | ||
| Jan 8, 2026 | Other acquisition or disposition (see the filing) | +20,570 | 20,570 See Footnote | Filing · EDGAR | ||
| Jan 8, 2026 | Gift | −34,000 | 5,147 See Footnote | Filing · EDGAR | ||
| Jan 8, 2026 | Other acquisition or disposition (see the filing) | +34,000 | 34,000 See Footnote | Filing · EDGAR | ||
| Dec 2, 2025 | Shares withheld for tax or exercise price | −135 | $79.78 | $11K | 8,179 direct | Filing · EDGAR |
240 earlier transactions are in the filing list below.
